Size at birth and risk of breast cancer: update from a prospective population-based study

European Journal of Epidemiology

Volumn 30, Issue 6, 2015, Pages 485-492

  Sandvei, Marie Søfteland ^a,b   Lagiou, Pagona ^c,d   Romundstad, Pål Richard ^a   Trichopoulos, Dimitrios ^c,d   Vatten, Lars Johan ^a,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORDLAND HOSPITAL   (Norway)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Birth length; Birth size; Breast cancer; Population based; Prospective

Indexed keywords

ADULT; ARTICLE; BIRTH LENGTH; BIRTH SIZE; BIRTH WEIGHT; BODY HEIGHT; BODY SIZE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; FEMALE; FOLLOW UP; HEAD CIRCUMFERENCE; HIGH RISK PATIENT; HUMAN; LENGTH; MAJOR CLINICAL STUDY; MATERNAL AGE; MIDDLE AGED; NORWAY; NORWEGIAN (PEOPLE); PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PLACENTA WEIGHT; PROSPECTIVE STUDY; AGED; BREAST NEOPLASMS; HEALTH SURVEY; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; PROCEDURES; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIRTH WEIGHT; BODY HEIGHT; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MIDDLE AGED; NORWAY; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS;

EID: 84933679351     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0045-2     Document Type: Article

References (40)

1. Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet. 1990;335:939–40.
2. Vatten LJ, Nilsen TI, Tretli S, Trichopoulos D, Romundstad PR. Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer. 2005;114:461–4.
3. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat. 1992;23:211–8.
4. Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P. Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer. 2008;122:481–5.
5. Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011;365:1304–14.
6. Adami HO, Lagiou P, Trichopoulos D. Breast cancer following diethylstilbestrol exposure in utero: insights from a tragedy. Eur J Epidemiol. 2012;27:1–3.
7. Lagiou P, Samoli E, Okulicz W, Xu B, Lagiou A, Lipworth L, et al. Maternal and cord blood hormone levels in the United States and China and the intrauterine origin of breast cancer. Ann Oncol. 2011;22:1102–8.
8. Michels KB, Xue F. Role of birthweight in the etiology of breast cancer. Int J Cancer. 2006;119:2007–25.
9. dos Santos Silva I, De Stavola B, McCormack V. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 2008;5:e193.
10. Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY, et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res. 2008;10:R8.
11. Savarese TM, Strohsnitter WC, Low HP, Liu Q, Baik I, Okulicz W, et al. Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res. 2007;9:R29.
12. Strohsnitter WC, Savarese TM, Low HP, Chelmow DP, Lagiou P, Lambe M, et al. Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk. Br J Cancer. 2008;98:660–3.
13. Qiu L, Low HP, Chang CI, Strohsnitter WC, Anderson M, Edmiston K, et al. Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life. Ann Oncol. 2012;23:245–50.
14. Lagiou P, Hsieh CC, Samoli E, Lagiou A, Xu B, Yu GP, et al. Associations of placental weight with maternal and cord blood hormones. Ann Epidemiol. 2013;23:669–73.
15. Vatten LJ, Maehle BO, Lund Nilsen TI, Tretli S, Hsieh CC, Trichopoulos D, et al. Birth weight as a predictor of breast cancer: a case-control study in Norway. Br J Cancer. 2002;86:89–91.
16. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet. 1992;340:1015–8.
17. Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D. Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst. 1997;89:71–6.
18. Lagiou P, Samoli E, Lagiou A, Hsieh CC, Adami HO, Trichopoulos D. Maternal height, pregnancy estriol and birth weight in reference to breast cancer risk in Boston and Shanghai. Int J Cancer. 2005;117:494–8.
19. Lagiou P, Trichopoulos D, Hsieh CC. Is maternal height a risk factor for breast cancer? Eur J Cancer Prev. 2013;22:389–90.
20. Heinonen S, Taipale P, Saarikoski S. Weights of placentae from small-for-gestational age infants revisited. Placenta. 2001;22:399–404.
21. Thame M, Osmond C, Bennett F, Wilks R, Forrester T. Fetal growth is directly related to maternal anthropometry and placental volume. Eur J Clin Nutr. 2004;58:894–900.
22. Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D, Adami HO. Perinatal characteristics and adult mammographic patterns. Int J Cancer. 1995;61:177–80.
23. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:1159–69.
24. Xue F, Michels KB. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol. 2007;8:1088–100.
25. Potischman N, Troisi R. In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control. 1999;10:561–73.
26. Boyd PA, Scott A. Quantitative structural studies on human placentas associated with pre-eclampsia, essential hypertension and intrauterine growth retardation. Br J Obstet Gynaecol. 1985;92:714–21.
27. Akhlaq M, Nagi AH, Yousaf AW. Placental morphology in pre-eclampsia and eclampsia and the likely role of NK cells. Indian J Pathol Microbiol. 2012;55:17–21.
28. Teasdale F. Histomorphometry of the human placenta in maternal preeclampsia. Am J Obstet Gynecol. 1985;152:25–31.
29. Risnes KR, Romundstad PR, Nilsen TI, Eskild A, Vatten LJ. Placental weight relative to birth weight and long-term cardiovascular mortality: findings from a cohort of 31,307 men and women. Am J Epidemiol. 2009;170:622–31.
30. Burkhardt T, Schaffer L, Schneider C, Zimmermann R, Kurmanavicius J. Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. Eur J Obstet Gynecol Reprod Biol. 2006;128:248–52.
31. Farrar D, Airey R, Law GR, Tuffnell D, Cattle B, Duley L. Measuring placental transfusion for term births: weighing babies with cord intact. BJOG Int J Obstet Gynaecol. 2011;118:70–5.
32. Lundberg C, Oian P, Klingenberg C. Umbilical cord clamping at birth–practice in Norwegian maternity wards. Tidsskr Nor Laegeforen. 2013;133:2369–73.
33. Johnson TS, Engstrom JL, Gelhar DK. Intra- and interexaminer reliability of anthropometric measurements of term infants. J Pediatr Gastroenterol Nutr. 1997;24:497–505.
34. Lagiou P, Hsieh CC, Trichopoulos D, Xu B, Wuu J, Mucci L, et al. Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol. 2003;32:193–8.
35. Lagiou P, Hsieh CC, Lipworth L, Samoli E, Okulicz W, Troisi R, et al. Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. Br J Cancer. 2009;100:1794–8.
36. Lagiou P, Samoli E, Hsieh CC, Lagiou A, Xu B, Yu GP, et al. Maternal and cord blood hormones in relation to birth size. Eur J Epidemiol. 2014;29:343–51.
37. Horn J, Alsaker MD, Opdahl S, Engstrom MJ, Tretli S, Haugen OA, et al. Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women. Int J Cancer. 2014;135:2678–86.
38. Horn J, Opdahl S, Engstrom MJ, Romundstad PR, Tretli S, Haugen OA, et al. Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women. Cancer Causes Control. 2014;25:881–9.
39. Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, et al. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012;131:159–67.
40. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103:250–63.